Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q4482372> ?p ?o }
Showing triples 1 to 53 of
53
with 100 triples per page.
- Q4482372 subject Q22230916.
- Q4482372 subject Q8556383.
- Q4482372 subject Q8647962.
- Q4482372 subject Q8792160.
- Q4482372 subject Q8878420.
- Q4482372 subject Q9546190.
- Q4482372 abstract "Fesoterodine (INN, used as the fumarate under the brand name Toviaz) is an antimuscarinic drug developed by Schwarz Pharma AG to treat overactive bladder syndrome (OAB). It was approved by the European Medicines Agency in April 2007, the US Food and Drug Administration on October 31, 2008 and Health Canada on February 9, 2012.Fesoterodine is a prodrug. It is broken down into its active metabolite, 5-hydroxymethyl tolterodine, by plasma esterases.".
- Q4482372 atcPrefix "G04".
- Q4482372 atcSuffix "BD11".
- Q4482372 bioavailability "52.0".
- Q4482372 casNumber "286930-03-8".
- Q4482372 drugbank "DB06702".
- Q4482372 fdaUniiCode "621G617227".
- Q4482372 iupacName "[2-[(1R)-3-(Di(propan-2-yl)amino)-1-phenylpropyl]-4-(hydroxymethyl)phenyl] 2-methylpropanoate".
- Q4482372 pubchem "6918558".
- Q4482372 thumbnail Fesoterodine.svg?width=300.
- Q4482372 wikiPageWikiLink Q1057591.
- Q4482372 wikiPageWikiLink Q130146.
- Q4482372 wikiPageWikiLink Q139857.
- Q4482372 wikiPageWikiLink Q14864419.
- Q4482372 wikiPageWikiLink Q14864427.
- Q4482372 wikiPageWikiLink Q204711.
- Q4482372 wikiPageWikiLink Q22230916.
- Q4482372 wikiPageWikiLink Q3001265.
- Q4482372 wikiPageWikiLink Q418750.
- Q4482372 wikiPageWikiLink Q424312.
- Q4482372 wikiPageWikiLink Q603741.
- Q4482372 wikiPageWikiLink Q824258.
- Q4482372 wikiPageWikiLink Q8556383.
- Q4482372 wikiPageWikiLink Q8647962.
- Q4482372 wikiPageWikiLink Q874632.
- Q4482372 wikiPageWikiLink Q8792160.
- Q4482372 wikiPageWikiLink Q8878420.
- Q4482372 wikiPageWikiLink Q902046.
- Q4482372 wikiPageWikiLink Q9368.
- Q4482372 wikiPageWikiLink Q9377.
- Q4482372 wikiPageWikiLink Q9546190.
- Q4482372 atcPrefix "G04".
- Q4482372 atcSuffix "BD11".
- Q4482372 bioavailability "52.0".
- Q4482372 casNumber "286930".
- Q4482372 drugbank "DB06702".
- Q4482372 iupacName "[2-[-3--1-phenylpropyl]-4-phenyl] 2-methylpropanoate".
- Q4482372 pubchem "6918558".
- Q4482372 unii "621".
- Q4482372 type ChemicalSubstance.
- Q4482372 type Drug.
- Q4482372 type ChemicalObject.
- Q4482372 type Thing.
- Q4482372 type Q8386.
- Q4482372 comment "Fesoterodine (INN, used as the fumarate under the brand name Toviaz) is an antimuscarinic drug developed by Schwarz Pharma AG to treat overactive bladder syndrome (OAB). It was approved by the European Medicines Agency in April 2007, the US Food and Drug Administration on October 31, 2008 and Health Canada on February 9, 2012.Fesoterodine is a prodrug. It is broken down into its active metabolite, 5-hydroxymethyl tolterodine, by plasma esterases.".
- Q4482372 label "Fesoterodine".
- Q4482372 depiction Fesoterodine.svg.